COMMITTEE ON PROBLEMS OF DRUG DEPENDENCE ANNUAL MEETING

药物依赖问题委员会（CPDD）将举行第52届 1990年6月11日至14日在弗吉尼亚州里士满举行的年度科学会议。 那里 为期四天的科学会议将由志愿者组成， 口头介绍和海报会议以及一些杰出的 及时的座谈会。 CPDD计划委员会选择了以下人员 从大量专题讨论会中选出专题讨论会（和主席 提交的提案：“滥用药物受体的现状”（埃里克 Simon和Michael Kuhar），“阿片类药物和免疫系统”（亚瑟法莱克和 John Madden），“麻醉剂拮抗剂的治疗潜力”（William Dewey和John Holleman），“表征和分子生物学的 多种阿片受体：更新”（埃里克西蒙），“目前的趋势， 滥用药物的化学和药理学”（Brian De Costa和Andrew Thurkauf），“海洛因和可卡因中的神经阿片样物质和多巴胺相互作用 依赖”（杰克门德尔松和南希梅洛），和“大麻”（比利R。 Martin）。 可能会安排一次或两次额外的专题讨论会。 全体会议和颁奖讲座以及卫星会议， CPDD的药物评价计划，专业研讨会将完成 程序. 会议记录将作为NIDA档案专著出版。 专题论文将包括研讨会论文，全体会议讲座，志愿者 CPDD药物评价计划的论文和完整报告。 的 会议记录仍然是重要的科学 在药物滥用研究的各个方面开展工作。

The Committee on Problems of Drug Dependence (CPDD) will hold its 52nd Annual Scientific Meeting in Richmond, VA, June 11 through 14, 1990. There will be four days of scientific sessions which will be made up of volunteer oral presentations and poster sessions as well as a number of outstanding timely symposia. The CPDD program Committee has selected the following symposia (and chairpersons) from among a larger number of symposium proposal submitted: "Current Status on Receptors of Drugs of Abuse" (Eric Simon and Michael Kuhar), "Opioids and the Immune System" (Arthur Falek and John Madden), "Therapeutic Potential of Narcotic Antagonists" (William Dewey and John Holaday), "Characterization and Molecular Biology of Multiple Opioid Receptors: an Update" (Eric Simon), "Current Trends in the Chemistry and Pharmacology of Drugs of Abuse" (Brian De Costa and Andrew Thurkauf), "Neural Opioid and Dopamine Interactions in Heroin and Cocaine Dependence" (Jack Mendelson and Nancy Mello), and "Cannabinoids" (Billy R. Martin). One or two additional symposia may be scheduled. Plenary and award lectures as well as satellite meetings, reports from the drug evaluation program of CPDD, and specialty workshops will complete the program. The proceedings will be published as an archival NIDA Monograph. The monograph will contain symposium papers, plenary lectures, volunteer papers, and complete reports of the CPDD drug evaluation program. The Proceedings continue to be a valuable compendium of important scientific work in all aspects of drug abuse research.